Jaundice: Clinical Meaning

Hepatitis

Hepatitis is inflammation of the liver, most commonly caused by viral infections (Hepatitis A, B, C, D, E). It can also result from alcohol use, toxins, or autoimmune conditions. Symptoms include jaundice, fatigue, abdominal pain, and dark urine.

Liver Cirrhosis

Liver cirrhosis is advanced scarring (fibrosis) of the liver caused by long-term damage from hepatitis, alcohol abuse, or fatty liver disease. As scar tissue replaces healthy tissue, the liver loses its ability to function properly.

Pancreatitis

Pancreatitis is inflammation of the pancreas, which can be acute (sudden) or chronic (long-term). Gallstones and heavy alcohol use are the most common causes. It causes severe upper abdominal pain that may radiate to the back, nausea, and vomiting.

Gallstones

Gallstones are hardened deposits of digestive fluid that form in the gallbladder. They can range from sand-grain size to golf-ball size. Many are asymptomatic, but when they block a duct they cause severe 'biliary colic' pain in the upper right abdomen.

Liver Cancer (Hepatocellular Carcinoma)

Hepatocellular carcinoma typically develops in the setting of chronic liver disease or cirrhosis due to hepatitis B, hepatitis C, or alcohol. It is a leading cause of cancer death globally.

Pancreatic Cancer

Pancreatic cancer has one of the lowest survival rates of all cancers, largely due to late-stage diagnosis. Symptoms include jaundice, weight loss, abdominal pain, and new-onset diabetes; most cases are adenocarcinomas.

Bile Duct Cancer (Cholangiocarcinoma)

Cholangiocarcinoma arises from the bile duct epithelium and often presents with obstructive jaundice, weight loss, and abdominal pain. It is typically diagnosed at an advanced stage with limited treatment options.

Hepatitis C

Hepatitis C is a blood-borne viral infection causing chronic liver inflammation that can progress to cirrhosis and liver cancer over decades. Direct-acting antiviral therapy achieves cure rates above 95%.

Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD is the accumulation of fat in liver cells not caused by alcohol, affecting up to 25% of adults globally. It ranges from simple steatosis to NASH (non-alcoholic steatohepatitis), which can progress to cirrhosis; lifestyle modification is the primary treatment.

Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency is a genetic disorder causing insufficient production of a protease inhibitor, leading to early-onset emphysema (especially in smokers) and liver disease. Augmentation therapy is available for the lung manifestations.

Echinococcosis (Hydatid Disease)

Echinococcosis is caused by larval stages of Echinococcus tapeworms, forming slowly growing cysts primarily in the liver and lungs. It is acquired from contact with infected dogs or contaminated food. Surgical removal and albendazole are the main treatments.

Leishmaniasis

Leishmaniasis is caused by Leishmania protozoa transmitted by sandfly bites, presenting in visceral, cutaneous, or mucocutaneous forms. Visceral leishmaniasis (kala-azar) causes fever, splenomegaly, and pancytopaenia. Amphotericin B and miltefosine are first-line treatments.

Primary Biliary Cholangitis

Primary biliary cholangitis is a chronic autoimmune liver disease causing progressive bile duct destruction. Left untreated it leads to liver cirrhosis.

Hepatitis A

Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus, transmitted through contaminated food and water. Unlike hepatitis B and C, it does not cause chronic disease.

Autoimmune Hepatitis

Autoimmune hepatitis is chronic liver inflammation where the immune system attacks liver cells. It can lead to cirrhosis if untreated but generally responds well to immunosuppressive therapy.

Non-Alcoholic Fatty Liver Disease

NAFLD is excessive fat buildup in the liver of people who drink little or no alcohol. It ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with inflammation and fibrosis.